Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT) has appointed Dr. Ingrid Müller as Chief Operating Officer (COO), effective May 1, 2026.
Dr. Müller brings to the role more than 20 years of international leadership experience in the life sciences industry across operations, strategy, supply, procurement and R&D integration.
In a statement, Dr. Christian Wojczewski, CEO of Evotec, commented, “Ingrid has built a broad international leadership profile defined by strategic perspective, operational discipline and the ability to lead cross-functional execution and transformation. She joins Evotec at a pivotal time, contributing a highly complementary combination of operational, strategic and scientific understanding, as we continue to advance our growth transformation. Her expertise in operational efficiency and delivery will play a key part in the execution of our strategy in coming years. On behalf of the whole team, I’d like to welcome Ingrid to Evotec.”
